[go: up one dir, main page]

PT1216048E - Formulacoes lipidicas solidas que compreendem um inibidor de lipases e um ester de acido gordo de poliois - Google Patents

Formulacoes lipidicas solidas que compreendem um inibidor de lipases e um ester de acido gordo de poliois

Info

Publication number
PT1216048E
PT1216048E PT00964158T PT00964158T PT1216048E PT 1216048 E PT1216048 E PT 1216048E PT 00964158 T PT00964158 T PT 00964158T PT 00964158 T PT00964158 T PT 00964158T PT 1216048 E PT1216048 E PT 1216048E
Authority
PT
Portugal
Prior art keywords
comprehensing
fatty acid
acid ester
lipase inhibitor
polyester fatty
Prior art date
Application number
PT00964158T
Other languages
English (en)
Inventor
Paul Hadvary
Hans Lengsfeld
Hans Steffen
De Smidt Passchier Christiaan
Schmid Marcel
Small Donald Macfarland
Tardio Joseph
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8238989&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1216048(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PT1216048E publication Critical patent/PT1216048E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
PT00964158T 1999-09-13 2000-09-11 Formulacoes lipidicas solidas que compreendem um inibidor de lipases e um ester de acido gordo de poliois PT1216048E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99118179 1999-09-13

Publications (1)

Publication Number Publication Date
PT1216048E true PT1216048E (pt) 2005-04-29

Family

ID=8238989

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00964158T PT1216048E (pt) 1999-09-13 2000-09-11 Formulacoes lipidicas solidas que compreendem um inibidor de lipases e um ester de acido gordo de poliois

Country Status (36)

Country Link
US (1) US6703369B1 (pt)
EP (1) EP1216048B1 (pt)
JP (1) JP4217017B2 (pt)
KR (1) KR100523879B1 (pt)
CN (1) CN1197554C (pt)
AR (1) AR025609A1 (pt)
AT (1) ATE285783T1 (pt)
AU (1) AU769016B2 (pt)
BR (1) BRPI0013940B1 (pt)
CA (1) CA2383036C (pt)
CO (1) CO5210857A1 (pt)
CZ (1) CZ301844B6 (pt)
DE (1) DE60017156T2 (pt)
EG (1) EG24225A (pt)
ES (1) ES2233444T3 (pt)
GC (1) GC0000259A (pt)
HK (1) HK1049798B (pt)
HR (1) HRP20020206B1 (pt)
HU (1) HU229037B1 (pt)
IL (2) IL148570A0 (pt)
JO (1) JO2300B1 (pt)
MA (1) MA26817A1 (pt)
ME (1) ME00675B (pt)
MX (1) MXPA02002662A (pt)
MY (1) MY127430A (pt)
NO (1) NO328889B1 (pt)
NZ (1) NZ517396A (pt)
PE (1) PE20010661A1 (pt)
PL (1) PL199869B1 (pt)
PT (1) PT1216048E (pt)
RS (1) RS50373B (pt)
RU (1) RU2248218C2 (pt)
SI (1) SI1216048T1 (pt)
TR (1) TR200200605T2 (pt)
WO (1) WO2001019378A2 (pt)
ZA (1) ZA200201249B (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR025609A1 (es) * 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones lipidas solidas
KR100572785B1 (ko) * 2000-07-28 2006-04-19 에프. 호프만-라 로슈 아게 신규한 약학 조성물
US6730319B2 (en) * 2001-06-06 2004-05-04 Hoffmann-La Roche Inc. Pharmaceutical compositions having depressed melting points
US20030027786A1 (en) * 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition
DE10251963A1 (de) * 2002-11-08 2004-05-19 Lts Lohmann Therapie-Systeme Ag Transmucosale pharmazeutische Darreichungsform
US8372430B2 (en) 2002-12-17 2013-02-12 The Procter & Gamble Company Compositions, methods, and kits useful for the alleviation of gastrointestinal effects
AU2003225649C1 (en) * 2003-03-04 2009-10-22 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
FI20045076L (fi) * 2004-03-15 2005-09-16 Bioferme Oy Funktionaalinen elintarvike
CA2582767C (en) * 2004-10-25 2011-05-24 Japan Tobacco Inc. Solid formulation with improved solubility and stability and method for producing said formulation
KR100669497B1 (ko) * 2005-08-17 2007-01-16 보람제약주식회사 안정성과 용출률이 뛰어난 약리학적 조성물 및 그 제조방법
EP1808163A1 (en) * 2005-12-22 2007-07-18 Teva Pharmaceutical Industries Ltd. Compressed solid dosage forms with drugs of low solubility and process for making the same
CA2626234A1 (en) * 2005-12-22 2007-06-28 Teva Pharmaceutical Industries Ltd. Compressed solid dosage forms with drugs of low solubility and process for making the same
US20070148245A1 (en) * 2005-12-22 2007-06-28 Ilan Zalit Compressed solid dosage forms with drugs of low solubility and process for making the same
KR101252635B1 (ko) 2006-04-20 2013-04-10 (주)아모레퍼시픽 리파아제 저해제 및 친유성 오일흡수제를 포함하는 약학조성물 및 이로부터 제조된 경구 투여용 제제
KR100903504B1 (ko) * 2007-05-18 2009-06-17 강태용 비라칸사스 열매 추출물질을 포함하는 기능식품 및 체중 감소제
EP2076248A2 (en) * 2007-08-17 2009-07-08 Teva Pharmaceutical Industries Ltd. Methods and compositions for controlling the bioavailability of poorly soluble drugs
ATE477820T1 (de) * 2007-09-12 2010-09-15 Mader S R L Pharmazeutische zusammensetzungen zur oralen verabreichung bei der behandlung von adipositas- patienten
PL216542B1 (pl) 2008-03-20 2014-04-30 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku
US8309107B2 (en) 2008-10-06 2012-11-13 Banner Pharmacaps, Inc. Stable solutions of orlistat for pharmaceutical dosage forms
BRPI0901602B8 (pt) 2009-04-03 2021-05-25 Ems S/A formulação farmacêuticas
UA107369C2 (en) 2010-02-01 2014-12-25 Lab Bago S A Pharmaceutical composition with anti-obesity activity comprising a premixture of pure orlistat and preparation process
EP2486805A1 (en) * 2011-02-11 2012-08-15 Puratos N.V. An emulsion whippable at room-temperature
PL2671455T3 (pl) * 2011-04-14 2017-10-31 J Oil Mills Inc Frakcjonowany olej palmowy oraz kompozycja oleju i produkt spożywczy ją zawierający
CN102552168B (zh) * 2012-01-31 2013-08-07 杭州华东医药集团生物工程研究所有限公司 一种含有奥利司他的药物组合物及其制备方法
GB2501535A (en) 2012-04-26 2013-10-30 Sony Corp Chrominance Processing in High Efficiency Video Codecs
EA030444B1 (ru) * 2012-05-31 2018-08-31 Репрос Терапьютикс Инк. Способ лечения прогестеронзависимого состояния
WO2015063039A1 (en) 2013-10-28 2015-05-07 Nestec S.A. Monoacylglycerols for use in conjunction with a lipase inhibitor and/or diets low in fat and/or calories
CN115105476B (zh) * 2021-03-23 2023-11-14 山东新时代药业有限公司 一种奥利司他冻干口服制剂及其制备工艺

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (en) 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
FR2710264B1 (fr) * 1993-09-21 1995-12-08 Rocher Yves Biolog Vegetale Utilisation pour le traitement des peaux mixtes d'une quantité efficace de substances actives.
AU5185398A (en) * 1996-12-04 1998-06-29 James S Pincott Process and apparatus for making crumb rubber from scrap tyres
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
NZ336755A (en) 1997-02-05 2001-06-29 F Use of gastrointestinal lipase inhibitors in particular tetrahydrolipstatin (orlistat)
US6267952B1 (en) 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
WO2000009123A1 (en) * 1998-08-14 2000-02-24 F. Hoffmann-La Roche Ag Pharmaceutical compositions containing lipase inhibitors and chitosan
WO2000009122A1 (en) 1998-08-14 2000-02-24 F. Hoffmann-La Roche Ag Pharmaceutical compositions containing lipase inhibitors
AR025609A1 (es) * 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones lipidas solidas

Also Published As

Publication number Publication date
ATE285783T1 (de) 2005-01-15
HRP20020206B1 (en) 2011-02-28
WO2001019378A3 (en) 2001-05-10
PL199869B1 (pl) 2008-11-28
ES2233444T3 (es) 2005-06-16
IL148570A (en) 2007-03-08
RU2248218C2 (ru) 2005-03-20
CN1373659A (zh) 2002-10-09
MXPA02002662A (es) 2002-07-30
AU7517700A (en) 2001-04-17
HK1049798A1 (en) 2003-05-30
PE20010661A1 (es) 2001-06-25
BRPI0013940B1 (pt) 2016-06-21
JP4217017B2 (ja) 2009-01-28
RS50373B (sr) 2009-11-10
SI1216048T1 (en) 2005-06-30
EP1216048B1 (en) 2004-12-29
EP1216048A2 (en) 2002-06-26
HUP0202762A3 (en) 2005-04-28
HRP20020206A2 (en) 2004-04-30
DE60017156T2 (de) 2006-01-05
NO328889B1 (no) 2010-06-07
NO20021205D0 (no) 2002-03-12
CZ20021277A3 (cs) 2003-04-16
MA26817A1 (fr) 2004-12-20
BR0013940A (pt) 2002-05-14
EG24225A (en) 2008-11-10
AR025609A1 (es) 2002-12-04
TR200200605T2 (tr) 2002-08-21
US6703369B1 (en) 2004-03-09
MY127430A (en) 2006-11-30
PL356154A1 (en) 2004-06-14
MEP90908A (en) 2011-12-20
NO20021205L (no) 2002-03-12
JP2003509373A (ja) 2003-03-11
ZA200201249B (en) 2003-07-30
KR20020060177A (ko) 2002-07-16
AU769016B2 (en) 2004-01-15
DE60017156D1 (de) 2005-02-03
CA2383036A1 (en) 2001-03-22
RU2002107450A (ru) 2004-01-10
NZ517396A (en) 2003-10-31
HK1049798B (zh) 2005-08-05
WO2001019378A2 (en) 2001-03-22
IL148570A0 (en) 2002-09-12
CN1197554C (zh) 2005-04-20
CO5210857A1 (es) 2002-10-30
ME00675B (me) 2011-12-20
HUP0202762A2 (hu) 2003-01-28
JO2300B1 (en) 2005-09-12
CZ301844B6 (cs) 2010-07-07
HU229037B1 (en) 2013-07-29
KR100523879B1 (ko) 2005-10-26
YU13602A (sh) 2006-01-16
CA2383036C (en) 2006-01-10
GC0000259A (en) 2006-11-01

Similar Documents

Publication Publication Date Title
PT1216048E (pt) Formulacoes lipidicas solidas que compreendem um inibidor de lipases e um ester de acido gordo de poliois
IL153817A0 (en) Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
PT823895E (pt) Esteres de acidos gordos como composto bioactivos
HRP20041057A2 (en) Method and system for the esterification of fatty acids
AU6236900A (en) Method of preparing dimeric fatty acids and/or esters thereof
ID18276A (id) Metoda pembuatan ester asam lemak
IL148374A0 (en) Plants with modified polyunsaturated fatty acids
EP1218333A4 (en) NITRO FATTY ACIDS AND ANTI-INFLAMMATORY THIA
PL346149A1 (en) Amphoteric derivatives of aliphatic polyamines with fatty acids, esters or triglycerides
AU3843200A (en) Conjugated fatty acid esters
IL158908A0 (en) Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid ester
PT1213962E (pt) Formulacoes pesticidas que contem tensioactivo ester fosfato e lignossulfonato alcoxilado
EP1117374A4 (en) DICARBOXYLIC ACID ESTERS OF ALCOHOLIC ALCOHOLIC ALCOHOL
AU2091099A (en) Esters of conjugated linoleic acid or conjugated linolenic acid and uses thereof
ID17964A (id) Pembuatan ester surfaktan
AU2003225651A1 (en) Nematicidal fatty acid and fatty acid ester related compounds
BR9506806A (pt) Endurecimento de gorduras ácidos graxos ou ésteres do ácido graxo insaturados
DE59501040D1 (de) Quaternierte Triethanolaminfettsäureester
AU2002343530A1 (en) Esters of aromatic alkoxylated alcohols and fatty carboxylic acids
DE59913680D1 (de) Fettsäurepartialester von Polyolen
AU8021000A (en) Method for the direct esterification of sorbitol with fatty acids
AU4215997A (en) Esters of unsaturated fatty acids
BR9703374A (pt) Misturas tensoativas de acilovialcanossulfonatos e ésteres de ácidos graxos
GB9705102D0 (en) Presentation of fatty acids
AU2002357948A1 (en) Esterification of fatty acids in oil